Antimicrobial Stewardship in the Treatment of Infections Among Patients With Cystic Fibrosis

[1] Dellit TH(2007)Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 159-177

[2] Owens RC(2005)Antimicrobial stewardship programs in health care systems Clin Micro Rev 18 638-656

[3] McGowan JE(2015)Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital’s intensive care and intermediate care units Infect Control Hosp Epidemiol 33 368-373

[4] Gerding DN(2008)Electronic antibiotic stewardship—reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting J Antimicrob Chemother 62 608-616

[5] Weinstein RA(2015)Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting J Antimicrob Chemother 70 1219-1225

[6] Burke JP(2015)Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients a controlled interrupted time series analysis Infect Control Hosp Epidemiol 33 354-361

[7] MacDougall C(2001)Implementing practice guidelines for appropriate antimicrobial usage: a systematic review Med Care 39 II-55-II-69

[8] Polk RE(1999)Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit Crit Care Med 27 2118-2124

[9] Lewis GJ(2014)Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis J Antimicrob Chemother 69 1748-1754

[10] Fang X(2009)Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa Antimicrob Agents and Chemother 53 1983-1986

[1] Dellit TH(2007)Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 159-177

[2] Owens RC(2005)Antimicrobial stewardship programs in health care systems Clin Micro Rev 18 638-656

[3] McGowan JE(2015)Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital’s intensive care and intermediate care units Infect Control Hosp Epidemiol 33 368-373

[4] Gerding DN(2008)Electronic antibiotic stewardship—reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting J Antimicrob Chemother 62 608-616

[5] Weinstein RA(2015)Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting J Antimicrob Chemother 70 1219-1225

[6] Burke JP(2015)Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients a controlled interrupted time series analysis Infect Control Hosp Epidemiol 33 354-361

[7] MacDougall C(2001)Implementing practice guidelines for appropriate antimicrobial usage: a systematic review Med Care 39 II-55-II-69

[8] Polk RE(1999)Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit Crit Care Med 27 2118-2124

[9] Lewis GJ(2014)Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis J Antimicrob Chemother 69 1748-1754

[10] Fang X(2009)Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa Antimicrob Agents and Chemother 53 1983-1986